Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_assertion type Assertion NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_head.
- NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_assertion wasGeneratedBy ECO_0000203 NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_provenance.
- NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_assertion wasDerivedFrom befree-2016 NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_provenance.
- NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_assertion SIO_000772 14735202 NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_provenance.
- NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_assertion evidence source_evidence_literature NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_provenance.
- NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_assertion description "[Epigenetic inactivation of RASSF1A was first described in lung and breast cancers and subsequently in a wide range of human cancers including neuroblastoma, Wilms' tumour and renal cell carcinoma (RCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428974.RA66c1qsvM65bwshqqc8Nd5EG-Osi8soOU1WL9c0S-iPM130_provenance.